Who will receive iodine-131 therapy in thyrotoxicosis?
Nyström, E.; Berg, G.
Lakartidningen 89(51-52): 4483
1992
ISSN/ISBN: 0023-7205 PMID: 1469993 Document Number: 392843
Document emailed within 1 workday
Related Documents
Iskandar, S.B.; Jordan, R.M.; Richard, M.J.; Peiris, A.N. 2004: Treating amiodarone-induced thyrotoxicosis with radioactive iodine Tennessee Medicine: Journal of the Tennessee Medical Association 97(9): 408-410Paindakhel, S.M.; Begum, N.; Shah, H.; Ahmad, I. 1980: Iodine induced thyrotoxicosis--case reports and review of literature Jpma. Journal of the Pakistan Medical Association 30(5): 122-124
Felt, V.; Vána, S.; Zamrazil, V. 1971: Effect of adrenergic blockade by trimepranol and propranolol on protein iodine and the severity of thyrotoxicosis Casopis Lekaru Ceskych 110(25): 595-597
Herrmann, J. 1981: Excess of iodine: danger, prevention and therapy in the endemic iodine-deficient region of the Federal Republic of Germany Verhandlungen der Deutschen Gesellschaft für Innere Medizin 87: 418-424
2003: Tolerable pain therapy in rheumatism saves long-term costs. Despite this most COX-2 candidates receive conventional NSAID therapy MMWFortschrittederMedizin 145(29-30): 61
Nakayama, S. 1970: Studies on the hematological changes after administration of therapeutic dosis of radioactive iodine. II. Changes of the peripheral blood and bone marrow after radioactive iodine therapy for hyperthyroidism Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 33(5): 578-597
Greer, M.A. 1986: Historical role of endemic goiter in elucidating the importance of iodine nutrition, the function and control of thyroid gland, the structure of thyroid hormone, and the use of antithyroid drugs in thyrotoxicosis Endocrinologia Experimentalis 20(1): 9-16
Leal Hernández, M.; Abellán Alemán, J.; García Sánchez, F.A.; Martínez Selva, J.M. 1998: Do our patients wish to receive hormone replacement therapy during menopause? Myths that persist Atencion Primaria 22(8): 542
Zhang, N.; Tong, Y.-j.; Shan, Z.-y.; Teng, W.-p. 2006: Effect of chronic mild and moderate iodine excess on thyroid anti-oxidative ability of iodine deficiency and non-iodine deficiency Wistar rats Zhonghua Yi Xue Za Zhi 86(18): 1274-1278
Hesse, V.; Rönnefarth, G.; Sander, I.; Groppel, B.; Bauch, K.H. 1988: Initial results of a preventive iodine program in East Germany--incidence of goiter and the iodine supply in children before and after the preventive use of iodine Kinderarztliche Praxis 56(5): 233-240
Schumm-Draeger, P.M. 1993: Drug therapy of goiter. Iodine, thyroid hormones or combined therapy Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 48(12): 592-598
Di Francia, R.; Siesto, R.S.; Valente, D.; Spart, D.; Berretta, M. 2012: Pharmacogenomics panel test for prevention toxicity in patient who receive Fluoropirimidine/Oxaliplatin-based therapy European Review for Medical and Pharmacological Sciences 16(9): 1211-1217
Xiao, Y.; Ji, G.; Tian, C.; Li, H.; Biao, W.; Hu, Z. 2014: Acceptability and factors associated with willingness to receive short messages for improving antiretroviral therapy adherence in China Aids Care 26(8): 952-958
Korobchenko, Z.A.; Matveenko, E.G. 1984: Changes in the ECG ventricular gradient before and after the drug therapy of thyrotoxicosis Problemy Endokrinologii 30(2): 18-21
Erikssen, J. 1970: Beta-adrenergic blocking therapy in thyrotoxicosis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(11): 1206-1210
Sonne, H.S.; Larsen, B.; Asfeldt, V.H. 1993: Radioiodine therapy of thyrotoxicosis in a central hospital Ugeskrift for Laeger 155(43): 3483-3486
Skorliakov, A.V.; Bystrenin, M.A.; Voloshinova, E.V. 2007: The character and structure of infectious complications in patients with chronic renal failure, who received or did not receive replacement therapy (hemodialysis) Klinicheskaia Meditsina 85(10): 59-61
Bahena, J.; Labastida Almendaro, S.; Ayala Hernández, J.R.; Fernández Orozco, A. 1998: Impact of the interval between surgery and radiotherapy in the initial phases of breast cancer in patients who did not receive systemic adjuvant therapy Ginecologia y Obstetricia de Mexico 66: 87-91
Fesenko, V.P.; Protsenko, V.A.; Klishevich, I.B.; Babalich, A.K. 1982: Kinin dynamics and inhibitor therapy of thyrotoxicosis patients Khirurgiia 8: 59-62
Czarnywojtek, A.; Czepczynski, R.; Ruchala, M.; Wasko, R.; Zgorzalewicz-Stachowiak, M.; Szczepanek, E.; Zamyslowska, H.; Bartkowiak, Z.; Florek, E.; Sowinski, J. 2009: Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT) Neuro Endocrinology Letters 30(2): 209-214